Followers | 39 |
Posts | 2870 |
Boards Moderated | 0 |
Alias Born | 12/06/2003 |
Tuesday, April 25, 2017 9:35:30 AM
Care to tell us all the differences?
The first to establish a biotech for the sole purpose of selling a proprietary vaccine adjuvant was Dr. Edgar Ribi, who wanted to call vaccines using his adjuvant theraccines since they would be intended to treat as well as prevent disease.
Before he was killed in a plane crash, Dr. Ribi's adjuvant was licensed to treat surface cancers on race horses.
After his death, Dr. Ribi's invention fell into the hands of clowns - one being Corixa, a favorite of the Seattle Billionaire's Biotech Boys Club and other informal names. Two members of the club were Warren Buffett and Bill Gates. Those of us opposing the sale to Corixa for a rummage sale price were a bit short on funding.
I was asked by a Wall Street Journal reporter why I had so little money in the stock. I asked him how much he would bet against the billionaires. In truth the price had already been reduced to rubble.
When Corixa inevitably went belly up, Dr. Ribi's adjuvant was the only thing of value that anyone wanted. The adjuvant went from shelf-sitting at Corixa to more commodius shelf-sitting at Glaxo but recently there has been new life. Glaxo's record-busting malaria vaccine is powered by the now venerable Ribi adjuvant and a former competitor extracted from the bark of the Chilean soap bark tree.
I beg to differ over the distinguished forebears of Yvonne Paterson's superior adjuvant. Remember Ribi's cured some cancers on horses by its lonesome self and even successfully treated some melanoma in an amateurish mix with ground-up cancer protusions.
Your wording seems to me to downplay the truly novel approach Advaxis has in treating fatal diseases, and thus it's financial potential.
Oh really? Even horse cancers and malaria can be fatal.
Would you rather call Lm a disease vector like Dan rather than a superior powering of treatment and preventive vaccines?
Best, Terry
Recent ADXS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:13:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:45 PM
- Form DEFM14C - Definitive information statement relating to merger or acquisition • Edgar (US Regulatory) • 03/05/2024 01:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:30:46 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 02/20/2024 10:22:48 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:26:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 07:16:21 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 04:58:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 01:27:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:51:21 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:18:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 02:04:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/21/2023 02:00:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 02:00:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:04:59 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 09:01:18 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/03/2023 03:46:10 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/03/2023 03:45:26 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/03/2023 03:43:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 11:08:02 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/31/2023 11:05:10 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 10/23/2023 10:45:21 AM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM